Literature DB >> 28011620

Wnt5a Drives an Invasive Phenotype in Human Glioblastoma Stem-like Cells.

Elena Binda1, Alberto Visioli2, Fabrizio Giani3, Nadia Trivieri4, Orazio Palumbo5, Silvia Restelli2, Fabio Dezi6, Tommaso Mazza4, Caterina Fusilli4, Federico Legnani7, Massimo Carella5, Francesco Di Meco7,8, Rohit Duggal9, Angelo L Vescovi1,2,3,4.   

Abstract

Brain invasion by glioblastoma determines prognosis, recurrence, and lethality in patients, but no master factor coordinating the invasive properties of glioblastoma has been identified. Here we report evidence favoring such a role for the noncanonical WNT family member Wnt5a. We found the most invasive gliomas to be characterized by Wnt5a overexpression, which correlated with poor prognosis and also discriminated infiltrating mesenchymal glioblastoma from poorly motile proneural and classical glioblastoma. Indeed, Wnt5a overexpression associated with tumor-promoting stem-like characteristics (TPC) in defining the character of highly infiltrating mesenchymal glioblastoma cells (Wnt5aHigh). Inhibiting Wnt5a in mesenchymal glioblastoma TPC suppressed their infiltrating capability. Conversely, enforcing high levels of Wnt5a activated an infiltrative, mesenchymal-like program in classical glioblastoma TPC and Wnt5aLow mesenchymal TPC. In intracranial mouse xenograft models of glioblastoma, inhibiting Wnt5a activity blocked brain invasion and increased host survival. Overall, our results highlight Wnt5a as a master regulator of brain invasion, specifically TPC, and they provide a therapeutic rationale to target it in patients with glioblastoma. Cancer Res; 77(4); 996-1007. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28011620     DOI: 10.1158/0008-5472.CAN-16-1693

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  32 in total

1.  Wnt-mediated endothelial transformation into mesenchymal stem cell-like cells induces chemoresistance in glioblastoma.

Authors:  Menggui Huang; Duo Zhang; Janet Y Wu; Kun Xing; Eujin Yeo; Chunsheng Li; Lin Zhang; Eric Holland; Lutian Yao; Ling Qin; Zev A Binder; Donald M O'Rourke; Steven Brem; Constantinos Koumenis; Yanqing Gong; Yi Fan
Journal:  Sci Transl Med       Date:  2020-02-26       Impact factor: 17.956

2.  LncRNA H19 Promotes Cell Proliferation, Migration, and Angiogenesis of Glioma by Regulating Wnt5a/β-Catenin Pathway via Targeting miR-342.

Authors:  Qin Zhou; Zheng-Zheng Liu; Heng Wu; Wei-Lu Kuang
Journal:  Cell Mol Neurobiol       Date:  2020-11-07       Impact factor: 5.046

3.  NSG-70, a new glioblastoma cell line with mixed proneural-mesenchymal features, associates NOTCH1-WNT5A signaling with stem cell maintenance and angiogenesis.

Authors:  Divya Kumari Singh; Pavan Kumar Mysuru Shivalingappa; Aman Sharma; Abir Mondal; Dattatraya Muzumdar; Anjali Shiras; Sharmila A Bapat
Journal:  J Neurooncol       Date:  2022-04-17       Impact factor: 4.130

4.  cRel and Wnt5a/Frizzled 5 Receptor-Mediated Inflammatory Regulation Reveal Novel Neuroprotectin D1 Targets for Neuroprotection.

Authors:  Jorgelina M Calandria; Khanh V Do; Sayantani Kala-Bhattacharjee; Andre Obenaus; Ludmila Belayev; Nicolas G Bazan
Journal:  Cell Mol Neurobiol       Date:  2022-05-27       Impact factor: 4.231

Review 5.  Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity.

Authors:  Ryan C Gimple; Kailin Yang; Matthew E Halbert; Sameer Agnihotri; Jeremy N Rich
Journal:  Nat Rev Cancer       Date:  2022-06-16       Impact factor: 69.800

Review 6.  Contribution of the Wnt Pathway to Defining Biology of Glioblastoma.

Authors:  Marton Tompa; Ferenc Kalovits; Adam Nagy; Bernadette Kalman
Journal:  Neuromolecular Med       Date:  2018-09-26       Impact factor: 3.843

Review 7.  WNT Signaling in Cancer Immunosurveillance.

Authors:  Lorenzo Galluzzi; Stefani Spranger; Elaine Fuchs; Alejandro López-Soto
Journal:  Trends Cell Biol       Date:  2018-09-13       Impact factor: 20.808

8.  Phenotypic Mapping of Pathologic Cross-Talk between Glioblastoma and Innate Immune Cells by Synthetic Genetic Tracing.

Authors:  Matthias Jürgen Schmitt; Carlos Company; Yuliia Dramaretska; Iros Barozzi; Andreas Göhrig; Sonia Kertalli; Melanie Großmann; Heike Naumann; Maria Pilar Sanchez-Bailon; Danielle Hulsman; Rainer Glass; Massimo Squatrito; Michela Serresi; Gaetano Gargiulo
Journal:  Cancer Discov       Date:  2020-12-23       Impact factor: 39.397

9.  Macropinocytosis requires Gal-3 in a subset of patient-derived glioblastoma stem cells.

Authors:  Laetitia Seguin; Soline Odouard; Francesca Corlazzoli; Sarah Al Haddad; Laurine Moindrot; Marta Calvo Tardón; Mayra Yebra; Alexey Koval; Eliana Marinari; Viviane Bes; Alexandre Guérin; Mathilde Allard; Sten Ilmjärv; Vladimir L Katanaev; Paul R Walker; Karl-Heinz Krause; Valérie Dutoit; Jann N Sarkaria; Pierre-Yves Dietrich; Érika Cosset
Journal:  Commun Biol       Date:  2021-06-10

Review 10.  Targeting Glioblastoma Stem Cells: A Review on Biomarkers, Signal Pathways and Targeted Therapy.

Authors:  Xuejia Tang; Chenghai Zuo; Pengchao Fang; Guojing Liu; Yongyi Qiu; Yi Huang; Rongrui Tang
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.